 |
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.1.1.8
- Cholinesterase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
An acylcholine + H2O = choline + a carboxylate
|
 |
 |
 |
 |
 |
acylcholine
|
+
|
H(2)O
|
=
|
choline
Bound ligand (Het Group name = )
matches with 46.15% similarity
|
+
|
carboxylate
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
|
 |
|
 |
|
|
Gene Ontology (GO) functional annotation
|
|
|
|
 |
 |
 |
|
 |
 |
 |
 |
|
 |
|
Cellular component
|
extracellular region
|
7 terms
|
 |
|
Biological process
|
metabolic process
|
11 terms
|
 |
|
Biochemical function
|
catalytic activity
|
8 terms
|
 |
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
DOI no:
|
J Biol Chem
278:41141-41147
(2003)
|
|
PubMed id:
|
|
|
|
|
| |
|
Crystal structure of human butyrylcholinesterase and of its complexes with substrate and products.
|
|
Y.Nicolet,
O.Lockridge,
P.Masson,
J.C.Fontecilla-Camps,
F.Nachon.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
Cholinesterases are among the most efficient enzymes known. They are divided
into two groups: acetylcholinesterase, involved in the hydrolysis of the
neurotransmitter acetylcholine, and butyrylcholinesterase of unknown function.
Several crystal structures of the former have shown that the active site is
located at the bottom of a deep and narrow gorge, raising the question of how
substrate and products enter and leave. Human butyrylcholinesterase (BChE) has
attracted attention because it can hydrolyze toxic esters such as cocaine or
scavenge organophosphorus pesticides and nerve agents. Here we report the
crystal structures of several recombinant truncated human BChE complexes and
conjugates and provide a description for mechanistically relevant non-productive
substrate and product binding. As expected, the structure of BChE is similar to
a previously published theoretical model of this enzyme and to the structure of
Torpedo acetylcholinesterase. The main difference between the experimentally
determined BChE structure and its model is found at the acyl binding pocket that
is significantly bigger than expected. An electron density peak close to the
catalytic Ser(198) has been modeled as bound butyrate.
|
|
|
|
|
| |
Selected figure(s)
|
|
|
| |
 |
 |
|
 |
|
 |
Figure 3.
FIG. 3. Difference Fourier electron density maps for bonded
and non-bonded butyrate. a, tetrahedral model. Despite the
restrains applied the C-O distance is 1.47
Å, and there is a residual negative electron density peak
at -5.7 between these two
atoms. The average B-factor for the buryrate moiety is 44
Å2 and that of the tetrahedral C atom is 51.1 Å2
(comparable values for the model with a 2.16-Å-long C-O
bond depicted in Fig. 2
are 41.7 and 41.4 Å, respectively). b, non-bonded butyrate
model. The C-O distance refines to 2.6
Å, and there is a negative peak at -3.7 below
the carboxylate carbon atom. The average B-factor for the
buryrate moiety is 41.7 Å2 and that of the carboxylate
carbon atom is 45.8 Å2.
|
 |
Figure 5.
FIG. 5. a, stereo view of the active site after soaking one
of the original crystals in a 100 mM choline solution. The
orientation is the same as in Fig. 2. b, stereo view of the same
structure rotated by 90° around an horizontal axis relative
to a. The catalytic serine side chain adopts two different
conformations: one where the O interacts with His438
and the other where it replaces a water molecule that interacted
with the main chain nitrogen of Ala^199, in the oxyanion hole.
c, stereo view of the active site of the soman-aged
butyrylthiocholine-BChE complex oriented as in Fig. 1. The
2.3-Å resolution difference Fourier omit map is depicted
in green. The covalently bound methylphosphonyl moiety occupies
the same position as in soman-aged TcAChE (35). As expected, the
quaternary ammonium group of butyrylthiocholine is located in
the -cation site, but the
substrate adopts a non-productive orientation (see "Results").
The omit Fourier electron density maps show that choline and
butyrylthiocholine occupy very similar positions and that the
alcohol function of the former and the carbonyl oxygen of the
latter establish hydrogen bonds with equivalent water molecules.
In all three panels the omit maps are depicted in green and are
contoured at a 3 level.
|
 |
|
|
|
| |
The above figures are
reprinted
by permission from the ASBMB:
J Biol Chem
(2003,
278,
41141-41147)
copyright 2003.
|
|
| |
Figures were
selected
by an automated process.
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
A.Weber,
H.Butterweck,
U.Mais-Paul,
W.Teschner,
L.Lei,
E.M.Muchitsch,
D.Kolarich,
F.Altmann,
H.J.Ehrlich,
and
H.P.Schwarz
(2011).
Biochemical, molecular and preclinical characterization of a double-virus-reduced human butyrylcholinesterase preparation designed for clinical use.
|
| |
Vox Sang, 100,
285-297.
|
 |
|
|
|
|
 |
F.Nachon,
E.Carletti,
M.Wandhammer,
Y.Nicolet,
L.M.Schopfer,
P.Masson,
and
O.Lockridge
(2011).
X-ray crystallographic snapshots of reaction intermediates in the G117H mutant of human butyrylcholinesterase, a nerve agent target engineered into a catalytic bioscavenger.
|
| |
Biochem J, 434,
73-82.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
L.Pezzementi,
F.Nachon,
and
A.Chatonnet
(2011).
Evolution of Acetylcholinesterase and Butyrylcholinesterase in the Vertebrates: An Atypical Butyrylcholinesterase from the Medaka Oryzias latipes.
|
| |
PLoS One, 6,
e17396.
|
 |
|
|
|
|
 |
L.Wang,
D.Du,
D.Lu,
C.T.Lin,
J.N.Smith,
C.Timchalk,
F.Liu,
J.Wang,
and
Y.Lin
(2011).
Enzyme-linked immunosorbent assay for detection of organophosphorylated butyrylcholinesterase: A biomarker of exposure to organophosphate agents.
|
| |
Anal Chim Acta, 693,
1-6.
|
 |
|
|
|
|
 |
M.Amitay,
and
A.Shurki
(2011).
Hydrolysis of organophosphate compounds by mutant butyrylcholinesterase: a story of two histidines.
|
| |
Proteins, 79,
352-364.
|
 |
|
|
|
|
 |
M.Komloova,
K.Musilek,
A.Horova,
O.Holas,
V.Dohnal,
F.Gunn-Moore,
and
K.Kuca
(2011).
Preparation, in vitro screening and molecular modelling of symmetrical bis-quinolinium cholinesterase inhibitors--implications for early myasthenia gravis treatment.
|
| |
Bioorg Med Chem Lett, 21,
2505-2509.
|
 |
|
|
|
|
 |
A.Gaydess,
E.Duysen,
Y.Li,
V.Gilman,
A.Kabanov,
O.Lockridge,
and
T.Bronich
(2010).
Visualization of exogenous delivery of nanoformulated butyrylcholinesterase to the central nervous system.
|
| |
Chem Biol Interact, 187,
295-298.
|
 |
|
|
|
|
 |
P.Masson,
and
O.Lockridge
(2010).
Butyrylcholinesterase for protection from organophosphorus poisons: catalytic complexities and hysteretic behavior.
|
| |
Arch Biochem Biophys, 494,
107-120.
|
 |
|
|
|
|
 |
Z.Ul-Haq,
W.Khan,
S.Kalsoom,
and
F.L.Ansari
(2010).
In silico modeling of the specific inhibitory potential of thiophene-2,3-dihydro-1,5-benzothiazepine against BChE in the formation of beta-amyloid plaques associated with Alzheimer's disease.
|
| |
Theor Biol Med Model, 7,
22.
|
 |
|
|
|
|
 |
E.Carletti,
N.Aurbek,
E.Gillon,
M.Loiodice,
Y.Nicolet,
J.C.Fontecilla-Camps,
P.Masson,
H.Thiermann,
F.Nachon,
and
F.Worek
(2009).
Structure-activity analysis of aging and reactivation of human butyrylcholinesterase inhibited by analogues of tabun.
|
| |
Biochem J, 421,
97.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
E.Podoly,
D.E.Shalev,
S.Shenhar-Tsarfaty,
E.R.Bennett,
E.Ben Assayag,
H.Wilgus,
O.Livnah,
and
H.Soreq
(2009).
The butyrylcholinesterase K variant confers structurally derived risks for Alzheimer pathology.
|
| |
J Biol Chem, 284,
17170-17179.
|
 |
|
|
|
|
 |
F.Gabel,
P.Masson,
M.T.Froment,
B.P.Doctor,
A.Saxena,
I.Silman,
G.Zaccai,
and
M.Weik
(2009).
Direct correlation between molecular dynamics and enzymatic stability: a comparative neutron scattering study of native human butyrylcholinesterase and its "aged" soman conjugate.
|
| |
Biophys J, 96,
1489-1494.
|
 |
|
|
|
|
 |
J.Shenouda,
P.Green,
and
L.Sultatos
(2009).
An evaluation of the inhibition of human butyrylcholinesterase and acetylcholinesterase by the organophosphate chlorpyrifos oxon.
|
| |
Toxicol Appl Pharmacol, 241,
135-142.
|
 |
|
|
|
|
 |
M.Amitay,
and
A.Shurki
(2009).
The structure of G117H mutant of butyrylcholinesterase: nerve agents scavenger.
|
| |
Proteins, 77,
370-377.
|
 |
|
|
|
|
 |
M.F.Montenegro,
M.T.Moral-Naranjo,
E.Muñoz-Delgado,
F.J.Campoy,
and
C.J.Vidal
(2009).
Hydrolysis of acetylthiocoline, o-nitroacetanilide and o-nitrotrifluoroacetanilide by fetal bovine serum acetylcholinesterase.
|
| |
FEBS J, 276,
2074-2083.
|
 |
|
|
|
|
 |
N.H.Barakat,
X.Zheng,
C.B.Gilley,
M.MacDonald,
K.Okolotowicz,
J.R.Cashman,
S.Vyas,
J.M.Beck,
C.M.Hadad,
and
J.Zhang
(2009).
Chemical synthesis of two series of nerve agent model compounds and their stereoselective interaction with human acetylcholinesterase and human butyrylcholinesterase.
|
| |
Chem Res Toxicol, 22,
1669-1679.
|
 |
|
|
|
|
 |
P.B.Juhl,
P.Trodler,
S.Tyagi,
and
J.Pleiss
(2009).
Modelling substrate specificity and enantioselectivity for lipases and esterases by substrate-imprinted docking.
|
| |
BMC Struct Biol, 9,
39.
|
 |
|
|
|
|
 |
S.Y.Chiou,
C.F.Huang,
M.T.Hwang,
and
G.Lin
(2009).
Comparison of active sites of butyrylcholinesterase and acetylcholinesterase based on inhibition by geometric isomers of benzene-di-N-substituted carbamates.
|
| |
J Biochem Mol Toxicol, 23,
303-308.
|
 |
|
|
|
|
 |
W.Yang,
Y.Pan,
F.Zheng,
H.Cho,
H.H.Tai,
and
C.G.Zhan
(2009).
Free-energy perturbation simulation on transition states and redesign of butyrylcholinesterase.
|
| |
Biophys J, 96,
1931-1938.
|
 |
|
|
|
|
 |
Y.Pan,
J.L.Muzyka,
and
C.G.Zhan
(2009).
Model of human butyrylcholinesterase tetramer by homology modeling and dynamics simulation.
|
| |
J Phys Chem B, 113,
6543-6552.
|
 |
|
|
|
|
 |
A.Frederick,
I.Tsigelny,
F.Cohenour,
C.Spiker,
E.Krejci,
A.Chatonnet,
S.Bourgoin,
G.Richards,
T.Allen,
M.H.Whitlock,
and
L.Pezzementi
(2008).
Acetylcholinesterase from the invertebrate Ciona intestinalis is capable of assembling into asymmetric forms when co-expressed with vertebrate collagenic tail peptide.
|
| |
FEBS J, 275,
1309-1322.
|
 |
|
|
|
|
 |
E.V.Radchenko,
G.F.Makhaeva,
V.V.Malygin,
V.B.Sokolov,
V.A.Palyulin,
and
N.S.Zefirov
(2008).
Modeling of the relationships between the structure of O-phosphorylated oximes and their anticholinesterase activity and selectivity using molecular field topology analysis (MFTA).
|
| |
Dokl Biochem Biophys, 418,
47-51.
|
 |
|
|
|
|
 |
F.Zheng,
W.Yang,
M.C.Ko,
J.Liu,
H.Cho,
D.Gao,
M.Tong,
H.H.Tai,
J.H.Woods,
and
C.G.Zhan
(2008).
Most efficient cocaine hydrolase designed by virtual screening of transition states.
|
| |
J Am Chem Soc, 130,
12148-12155.
|
 |
|
|
|
|
 |
J.P.Colletier,
D.Bourgeois,
B.Sanson,
D.Fournier,
J.L.Sussman,
I.Silman,
and
M.Weik
(2008).
Shoot-and-Trap: use of specific x-ray damage to study structural protein dynamics by temperature-controlled cryo-crystallography.
|
| |
Proc Natl Acad Sci U S A, 105,
11742-11747.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
M.F.Montenegro,
T.M.María,
M.P.de la Cadena,
F.J.Campoy,
E.Muñoz-Delgado,
and
C.J.Vidal
(2008).
Human butyrylcholinesterase components differ in aryl acylamidase activity.
|
| |
Biol Chem, 389,
425-432.
|
 |
|
|
|
|
 |
P.Masson,
M.T.Froment,
E.Gillon,
F.Nachon,
O.Lockridge,
and
L.M.Schopfer
(2008).
Kinetic analysis of effector modulation of butyrylcholinesterase-catalysed hydrolysis of acetanilides and homologous esters.
|
| |
FEBS J, 275,
2617-2631.
|
 |
|
|
|
|
 |
S.Y.Chiou,
Y.G.Wu,
and
G.Lin
(2008).
Activation mechanisms of butyrylcholinesterase by 2,4,6-trinitrotoluene, 3,3-dimethylbutyl-N-n-butylcarbamate, and 2-trimethylsilyl-ethyl-N-n-butylcarbamate.
|
| |
Appl Biochem Biotechnol, 150,
337-344.
|
 |
|
|
|
|
 |
L.R.Mikami,
S.Wieseler,
R.L.Souza,
L.M.Schopfer,
O.Lockridge,
and
E.A.Chautard-Freire-Maia
(2007).
Expression of three naturally occurring genetic variants (G75R, E90D, I99M) of the BCHE gene of human butyrylcholinesterase.
|
| |
Pharmacogenet Genomics, 17,
681-685.
|
 |
|
|
|
|
 |
M.C.Lin,
M.T.Hwang,
H.G.Chang,
C.S.Lin,
and
G.Lin
(2007).
Benzene-1,2-, 1,3-, and 1,4-di-N-substituted carbamates as conformationally constrained inhibitors of acetylcholinesterase.
|
| |
J Biochem Mol Toxicol, 21,
348-353.
|
 |
|
|
|
|
 |
M.F.Frasco,
J.P.Colletier,
M.Weik,
F.Carvalho,
L.Guilhermino,
J.Stojan,
and
D.Fournier
(2007).
Mechanisms of cholinesterase inhibition by inorganic mercury.
|
| |
FEBS J, 274,
1849-1861.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.N.Ngamelue,
K.Homma,
O.Lockridge,
and
O.A.Asojo
(2007).
Crystallization and X-ray structure of full-length recombinant human butyrylcholinesterase.
|
| |
Acta Crystallogr Sect F Struct Biol Cryst Commun, 63,
723-727.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.Darvesh,
R.Walsh,
and
E.Martin
(2007).
Homocysteine thiolactone and human cholinesterases.
|
| |
Cell Mol Neurobiol, 27,
33-48.
|
 |
|
|
|
|
 |
Y.Pan,
D.Gao,
W.Yang,
H.Cho,
and
C.G.Zhan
(2007).
Free energy perturbation (FEP) simulation on the transition states of cocaine hydrolysis catalyzed by human butyrylcholinesterase and its mutants.
|
| |
J Am Chem Soc, 129,
13537-13543.
|
 |
|
|
|
|
 |
B.M.Liederer,
and
R.T.Borchardt
(2006).
Enzymes involved in the bioconversion of ester-based prodrugs.
|
| |
J Pharm Sci, 95,
1177-1195.
|
 |
|
|
|
|
 |
D.Gao,
and
C.G.Zhan
(2006).
Modeling evolution of hydrogen bonding and stabilization of transition states in the process of cocaine hydrolysis catalyzed by human butyrylcholinesterase.
|
| |
Proteins, 62,
99.
|
 |
|
|
|
|
 |
D.Rochu,
C.Cléry-Barraud,
F.Renault,
A.Chevalier,
C.Bon,
and
P.Masson
(2006).
Capillary electrophoresis versus differential scanning calorimetry for the analysis of free enzyme versus enzyme-ligand complexes: in the search of the ligand-free status of cholinesterases.
|
| |
Electrophoresis, 27,
442-451.
|
 |
|
|
|
|
 |
I.Gazić,
A.Bosak,
G.Sinko,
V.Vinković,
and
Z.Kovarik
(2006).
Preparative HPLC separation of bambuterol enantiomers and stereoselective inhibition of human cholinesterases.
|
| |
Anal Bioanal Chem, 385,
1513-1519.
|
 |
|
|
|
|
 |
J.P.Colletier,
D.Fournier,
H.M.Greenblatt,
J.Stojan,
J.L.Sussman,
G.Zaccai,
I.Silman,
and
M.Weik
(2006).
Structural insights into substrate traffic and inhibition in acetylcholinesterase.
|
| |
EMBO J, 25,
2746-2756.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
P.J.Houghton,
Y.Ren,
and
M.J.Howes
(2006).
Acetylcholinesterase inhibitors from plants and fungi.
|
| |
Nat Prod Rep, 23,
181-199.
|
 |
|
|
|
|
 |
W.Luo,
Q.S.Yu,
S.S.Kulkarni,
D.A.Parrish,
H.W.Holloway,
D.Tweedie,
A.Shafferman,
D.K.Lahiri,
A.Brossi,
and
N.H.Greig
(2006).
Inhibition of human acetyl- and butyrylcholinesterase by novel carbamates of (-)- and (+)-tetrahydrofurobenzofuran and methanobenzodioxepine.
|
| |
J Med Chem, 49,
2174-2185.
|
 |
|
|
|
|
 |
Z.Prokop,
F.Oplustil,
J.DeFrank,
and
J.Damborský
(2006).
Enzymes fight chemical weapons.
|
| |
Biotechnol J, 1,
1370-1380.
|
 |
|
|
|
|
 |
A.Hamza,
H.Cho,
H.H.Tai,
and
C.G.Zhan
(2005).
Molecular dynamics simulation of cocaine binding with human butyrylcholinesterase and its mutants.
|
| |
J Phys Chem B, 109,
4776-4782.
|
 |
|
|
|
|
 |
C.G.Zhan,
and
D.Gao
(2005).
Catalytic mechanism and energy barriers for butyrylcholinesterase-catalyzed hydrolysis of cocaine.
|
| |
Biophys J, 89,
3863-3872.
|
 |
|
|
|
|
 |
D.Suárez,
and
M.J.Field
(2005).
Molecular dynamics simulations of human butyrylcholinesterase.
|
| |
Proteins, 59,
104-117.
|
 |
|
|
|
|
 |
F.Gabel,
M.Weik,
P.Masson,
F.Renault,
D.Fournier,
L.Brochier,
B.P.Doctor,
A.Saxena,
I.Silman,
and
G.Zaccai
(2005).
Effects of soman inhibition and of structural differences on cholinesterase molecular dynamics: a neutron scattering study.
|
| |
Biophys J, 89,
3303-3311.
|
 |
|
|
|
|
 |
M.I.Rodríguez-Franco,
M.I.Fernández-Bachiller,
C.Pérez,
A.Castro,
and
A.Martínez
(2005).
Design and synthesis of N-benzylpiperidine-purine derivatives as new dual inhibitors of acetyl- and butyrylcholinesterase.
|
| |
Bioorg Med Chem, 13,
6795-6802.
|
 |
|
|
|
|
 |
O.Lockridge,
L.M.Schopfer,
G.Winger,
and
J.H.Woods
(2005).
LARGE SCALE PURIFICATION OF BUTYRYLCHOLINESTERASE FROM HUMAN PLASMA SUITABLE FOR INJECTION INTO MONKEYS; A POTENTIAL NEW THERAPEUTIC FOR PROTECTION AGAINST COCAINE AND NERVE AGENT TOXICITY.
|
| |
J Med Chem Biol Radiol Def, 3,
nihms5095.
|
 |
|
|
|
|
 |
S.Darvesh,
R.S.McDonald,
A.Penwell,
S.Conrad,
K.V.Darvesh,
D.Mataija,
G.Gomez,
A.Caines,
R.Walsh,
and
E.Martin
(2005).
Structure-activity relationships for inhibition of human cholinesterases by alkyl amide phenothiazine derivatives.
|
| |
Bioorg Med Chem, 13,
211-222.
|
 |
|
|
|
|
 |
Y.Pan,
D.Gao,
W.Yang,
H.Cho,
G.Yang,
H.H.Tai,
and
C.G.Zhan
(2005).
Computational redesign of human butyrylcholinesterase for anticocaine medication.
|
| |
Proc Natl Acad Sci U S A, 102,
16656-16661.
|
 |
|
|
|
|
 |
A.W.Schüttelkopf,
and
D.M.van Aalten
(2004).
PRODRG: a tool for high-throughput crystallography of protein-ligand complexes.
|
| |
Acta Crystallogr D Biol Crystallogr, 60,
1355-1363.
|
 |
|
|
|
|
 |
F.Gabel,
M.Weik,
B.P.Doctor,
A.Saxena,
D.Fournier,
L.Brochier,
F.Renault,
P.Masson,
I.Silman,
and
G.Zaccai
(2004).
The influence of solvent composition on global dynamics of human butyrylcholinesterase powders: a neutron-scattering study.
|
| |
Biophys J, 86,
3152-3165.
|
 |
|
|
|
|
 |
J.Stojan,
L.Brochier,
C.Alies,
J.P.Colletier,
and
D.Fournier
(2004).
Inhibition of Drosophila melanogaster acetylcholinesterase by high concentrations of substrate.
|
| |
Eur J Biochem, 271,
1364-1371.
|
 |
|
|
|
|
 |
M.Weik,
X.Vernede,
A.Royant,
and
D.Bourgeois
(2004).
Temperature derivative fluorescence spectroscopy as a tool to study dynamical changes in protein crystals.
|
| |
Biophys J, 86,
3176-3185.
|
 |
|
|
|
|
 |
P.Masson,
B.N.Goldstein,
J.C.Debouzy,
M.T.Froment,
O.Lockridge,
and
L.M.Schopfer
(2004).
Damped oscillatory hysteretic behaviour of butyrylcholinesterase with benzoylcholine as substrate.
|
| |
Eur J Biochem, 271,
220-234.
|
 |
|
|
|
|
 |
P.Masson,
N.Bec,
M.T.Froment,
F.Nachon,
C.Balny,
O.Lockridge,
and
L.M.Schopfer
(2004).
Rate-determining step of butyrylcholinesterase-catalyzed hydrolysis of benzoylcholine and benzoylthiocholine. Volumetric study of wild-type and D70G mutant behavior.
|
| |
Eur J Biochem, 271,
1980-1990.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
codes are
shown on the right.
|
|